Proteomic Assessment of Preterm Birth

The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Preterm Birth Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Premature Birth Urogenital Diseases

Age range

18 year–60 year

Sex eligibility

Female

Study type

Observational

Primary location

Maricopa Integrated Health System, Phoenix, Arizona, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subject is 18 years or older.
Subject has a singleton pregnancy.
Subject is able to provide consent.

Exclusion criteria

Subject is pregnant with more than one fetus.
There is a known or suspected fetal anomaly.

Treatment and study plan

Primary outcomes

Spontaneous Preterm Birth

Time frame: August 2015

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Sera Prognostics, Inc.

Industry

Registry information

Acronym: PAPR

Important dates

Study start: 2011
Primary completion: 2014
Study completion: 2015
First posted: Jun 10, 2011
Registry last updated: Jun 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed